US Bancorp
HCAT icon

US Bancorp’s Health Catalyst HCAT Stock Holding History

US Bancorp’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-279
Closed -$1.26K – 4229
2025
Q1 		$1.26K Sell
279
-199
-42% -$1.05K ﹤0.01% 3952
2024
Q4 		$3.38K Hold
478
– – ﹤0.01% 3739
2024
Q3 		$3.89K Hold
478
– – ﹤0.01% 3650
2024
Q2 		$3.06K Sell
478
-1,932
-80% -$12.4K ﹤0.01% 3628
2024
Q1 		$18.1K Buy
2,410
+1,483
+160% +$13.5K ﹤0.01% 3135
2023
Q4 		$8.58K Sell
927
-1,477
-61% -$12.1K ﹤0.01% 3352
2023
Q3 		$24.3K Sell
2,404
-1,004
-29% -$12K ﹤0.01% 2786
2023
Q2 		$42.6K Sell
3,408
-852
-20% -$10.1K ﹤0.01% 2581
2023
Q1 		$49.7K Buy
4,260
+1,139
+36% +$14.5K ﹤0.01% 2516
2022
Q4 		$33.2K Buy
3,121
+476
+18% +$4.59K ﹤0.01% 2737
2022
Q3 		$26K Buy
2,645
+1,902
+256% +$25.2K ﹤0.01% 2895
2022
Q2 		$11K Sell
743
-8,517
-92% -$145K ﹤0.01% 3333
2022
Q1 		$242K Buy
9,260
+1,139
+14% +$32.3K ﹤0.01% 1859
2021
Q4 		$322K Sell
8,121
-1,555
-16% -$70.9K ﹤0.01% 1758
2021
Q3 		$483K Sell
9,676
-424
-4% -$23.1K ﹤0.01% 1534
2021
Q2 		$560K Sell
10,100
-86
-0.8% -$4.58K ﹤0.01% 1492
2021
Q1 		$477K Buy
10,186
+523
+5% +$25.3K ﹤0.01% 1527
2020
Q4 		$421K Sell
9,663
-546
-5% -$20.1K ﹤0.01% 1531
2020
Q3 		$374K Buy
10,209
+10,040
+5,941% +$341K ﹤0.01% 1485
2020
Q2 		$5K Buy
+169
New +$4.67K ﹤0.01% 3309

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp's HCAT Position: Q2 2025 in Review

US Bancorp sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 279 shares — an estimated $1.26K sold.

US Bancorp first reported a position in HCAT in Q2 2020 and held it in 20 quarters. The position peaked at $560K in Q2 2021. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • US Bancorp reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • US Bancorp sold 279 Health Catalyst shares in Q2 2025, an estimated $1.26K.
  • US Bancorp first reported a position in Health Catalyst in Q2 2020 and held it in 20 quarters.
  • US Bancorp's Health Catalyst position peaked at $560K in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on US Bancorp's 13F filing for Q2 2025, filed 24 Jul 2025.